mRNA, the beginning of a new influenza vaccine game
Proc Natl Acad Sci U S A
.
2022 Dec 13;119(50):e2217533119.
doi: 10.1073/pnas.2217533119.
Epub 2022 Dec 5.
Authors
Simone Pecetta
1
,
Rino Rappuoli
2
Affiliations
1
GlaxoSmithKline (GSK), 53100 Siena, Italy.
2
Fondazione Biotecnopolo di Siena, 53100 Siena, Italy.
PMID:
36469761
PMCID:
PMC9897424
DOI:
10.1073/pnas.2217533119
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Humans
Influenza Vaccines*
Influenza, Human* / prevention & control
RNA, Messenger
Vaccination
Substances
Influenza Vaccines
RNA, Messenger
Grants and funding
N.A./GSK